Benjamin Shaker - Dec 14, 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Dec 14, 2022
Transactions value $
-$539,653
Form type
4
Date filed
12/16/2022, 03:08 PM
Previous filing
Nov 18, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $56.3K +18.8K +73.17% $3.00* 44.4K Dec 14, 2022 Direct F1
transaction AGL Common Stock Sale -$328K -18.8K -42.25% $17.52 25.6K Dec 14, 2022 Direct F1, F2, F3
transaction AGL Common Stock Options Exercise $56.3K +18.8K +73.17% $3.00* 44.4K Dec 15, 2022 Direct F1
transaction AGL Common Stock Sale -$324K -18.8K -42.25% $17.26 25.6K Dec 15, 2022 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Options Exercise $0 -18.8K -16.4% $0.00 95.6K Dec 14, 2022 Common Stock 18.8K $3.00 Direct F5
transaction AGL Options (Right to buy) Options Exercise $0 -18.8K -19.61% $0.00 76.9K Dec 15, 2022 Common Stock 18.8K $3.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.32 to $18.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.99 to $17.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 These options were granted on December 30, 2016 and vested on September 14, 2021.